Hepatitis A News and Research

RSS

Hepatitis A (formerly known as ''infectious hepatitis'') is an acute infectious disease of the liver caused by the hepatitis A virus (HAV), which is most commonly transmitted by the fecal-oral route via contaminated food or drinking water.

Russia launches five-year, $2.9 billion plan to combat diseases

The Russian government has approved a five-year, $2.9 billion draft program to combat diseases, including HIV/AIDS, in an effort to improve the country's life expectancy, a spokesperson announced on Thursday, the AP/Guardian reports (AP/Guardian, 2/23).

27 Feb 2007

Gardasil reaction report released

The National Vaccine Information Center (NVIC) today released a new analysis of the federal Vaccine Adverse Event Reporting System (VAERS) reports of serious health problems following HPV vaccination (Merck's Gardasil) during the last six months of 2006.

21 Feb 2007

RNAi shows promise in gene therapy

Three years ago Mark Kay, MD, PhD, published the first results showing that a biological phenomenon called RNA interference could be an effective gene therapy technique. Since then he has used RNAi gene therapy to effectively shut down the viruses that cause hepatitis and HIV in mice.

19 Feb 2007

Jesse Jackson urges HIV awareness, testing, more research for a cure

The Rev. Jesse Jackson on Monday in Philadelphia at the 2007 National Conference on African-Americans and AIDS called for increased research funding to find a cure for HIV/AIDS, as well as more awareness about HIV testing, the Philadelphia Inquirer reports.

19 Feb 2007

Body Shop founder Roddick reveals she has Hepatitis C

Anita Roddick the founder of the Body Shop has revealed she is suffering from the disease Hepatitis C.

14 Feb 2007

ViroPharma receives orphan drug designation for Maribavir

ViroPharma Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for maribavir for prevention of cytomegalovirus (CMV) viremia and disease in the populations at-risk.

7 Feb 2007

Antipodean Pharma commences phase 2 trial in hepatitis C

Antipodean Pharmaceuticals has announced it has initiated a Phase 2 clinical trial of its lead compound MitoQ (mitoquinone) to investigate the drug's efficacy to reduce liver damage in patients with raised liver enzymes associated with the Hepatitis C virus (HCV).

5 Feb 2007

GAVI Alliance brings immunisation rates to record highs in poor countries

New data from the World Health Organization (WHO) show that the GAVI Alliance, a groundbreaking global initiative to increase access to children's vaccines, has brought immunisation rates to record highs in poor countries.

28 Jan 2007

FDA urged to review policy that bans MSM from donating blood

The American Red Cross and other organizations that collect donated blood are urging FDA to review a policy in effect since the early 1980s that prohibits men who have sex with men -- regardless of sexual activity, safer-sex practices or HIV status -- from donating blood, the San Jose Mercury News reports.

23 Jan 2007

Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes

Researchers open the way for improved study of hepatitis C virus by devising a novel virus culture system that allows replication of patient-isolated virus in nontransformed hepatocytes, instead of culture-adapted virus strains in transformed cell lines.

23 Jan 2007

New approach offers hope for an effective herpes vaccine

A researcher at Montana State University has called for an innovative, new approach in developing a vaccine against genital herpes.

10 Jan 2007

Substantial new scientific evidence supports medics in Libyan HIV court case

A team of international scientists have produced new information that questions the evidence against the six medics on trial in Libya accused of deliberately infecting Libyan children with HIV.

11 Dec 2006

New cancer treatments use body's own immune system to kill melanoma tumours

Scientists are claiming that the body's own immune system could be used to fight the most serious form of skin cancer, malignant melanoma.

13 Nov 2006

Liver damage can be reversed

Saint Louis University Liver Center scientists are presenting research today on a more effective way to treat hepatitis C patients who have been unresponsive to current drug therapies.

30 Oct 2006

Six medics fight for their life in Libyan re-trial as another child dies of AIDS

The death of a nine-year old girl from AIDS in Libya brings the death toll to 52 of children in a Benghazi hospital who were allegedly deliberately infected with the virus by six foreign medics.

30 Oct 2006

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

The Food and Drug Administration (FDA) has approved Tyzeka (telbivudine) for the treatment of adults with chronic hepatitis B (HBV), a serious viral infection that attacks the liver and can cause lifelong infection, scarring of the liver (cirrhosis), and eventually liver cancer, liver failure, and death.

26 Oct 2006

Eminent scientists support jailed medics in Libya

The case of the six medics currently on trial in Libya on charges that they deliberatly infected more than 400 children with HIV 1998, has hit international headlines due to the action of a group of prominent American scientists.

26 Oct 2006

Link discovered between common cold viruses and Alzheimer's disease

According to new research memory loss and Alzheimer's disease may be linked to the very viruses which cause the common cold.

24 Oct 2006

Local Chinese authorities declare HIV/AIDS NGO illegal, close operation

Local authorities on Wednesday declared a Xinjiang, China-based nongovernmental HIV/AIDS organization illegal and shut down its operation, according to Chang Kun, organizer of the project, AFP/Sunday Times reports (AFP/Sunday Times, 10/19).

22 Oct 2006

Heart transplant patients who receive a donor heart from a person with hepatitis C have a lower rate of survival

A shortage of cardiac organ donors results in a substantial number of deaths among persons awaiting cardiac transplantation. One potential approach for increasing the availability of donors is to broaden the criteria used to identify appropriate donors.

17 Oct 2006